Reaction Details |
| Report a problem with these data |
Target | C-X-C chemokine receptor type 4 |
---|
Ligand | BDBM50335557 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_708476 (CHEMBL1666142) |
---|
IC50 | 0.61±n/a nM |
---|
Citation | Murakami, T; Kumakura, S; Yamazaki, T; Tanaka, R; Hamatake, M; Okuma, K; Huang, W; Toma, J; Komano, J; Yanaka, M; Tanaka, Y; Yamamoto, N The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. Antimicrob Agents Chemother53:2940-8 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-X-C chemokine receptor type 4 |
---|
Name: | C-X-C chemokine receptor type 4 |
Synonyms: | C-X-C chemokine receptor type 4 | C-X-C chemokine receptor type 4 (CXCR4) | CD_antigen=CD184 | CXC-R4 | CXCR-4 | CXCR4 | CXCR4_HUMAN | FB22 | Fusin | HM89 | LCR1 | LESTR | Leukocyte-derived seven transmembrane domain receptor | NPYRL | SDF-1 receptor | Stromal cell-derived factor 1 receptor |
Type: | Enzyme |
Mol. Mass.: | 39754.61 |
Organism: | Homo sapiens (Human) |
Description: | P61073 |
Residue: | 352 |
Sequence: | MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVI
LVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNL
YSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEA
DDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKT
TVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPI
LYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
|
|
|
BDBM50335557 |
---|
n/a |
---|
Name | BDBM50335557 |
Synonyms: | CHEMBL1652605 | N,N-dipropyl-N'-[4-({[(1H-imidazol-2-yl)methyl][(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)benzyl]-N'-methylbutane-1,4-diamine tri-(2R,3R)-tartrate |
Type | Small organic molecule |
Emp. Form. | C28H45N7 |
Mol. Mass. | 479.7038 |
SMILES | CCCN(CCC)CCCCN(C)Cc1ccc(CN(Cc2ncc[nH]2)Cc2nccn2C)cc1 |
Structure |
|